SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Fowble B, Solin LJ, Schultz DJ, et al. Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. Int J Radiat Oncol Biol Phys. 1990; 19: 833-842.
  • 2
    Gage I, Recht A, Gelman R, et al. Long-term outcome following breast-conserving surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1995; 33: 245-251.
  • 3
    Smith TE, Lee D, Turner BC, et al. True recurrence versus new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys. 2000; 48: 1281-1289.
  • 4
    Huang E, Buchholz TA, Meric F, et al. Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences. Cancer. 2002; 95: 2059-2067.
  • 5
    Radiation Therapy Oncology Group. NSABP Protocol B-39/RTOG Protocol 0413: a randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer. Available at: www.rtog.org/members/protocols/0413/0413broadcast.html. Accessed December 21, 2009.
  • 6
    Livi L, Buonamici FB, Simontacchi G, et al. Accelerated partial breast irradiation with IMRT: new technical approach and interim analysis of acute toxicity in a phase III randomized clinical trial. Int J Radiat Oncol Biol Phys. 2010; 77: 509-515.
  • 7
    Polgar C, Fodor J, Major T, et al. Breast-conserving treatment with partial or whole breast irradiation for low-risk invasive breast carcinoma—5-year results of a randomized trial. Int J Radiat Oncol Biol Phys. 2007; 69: 694-702.
  • 8
    Dodwell DJ, Dyker K, Brown J, et al. A randomised study of whole-breast versus tumor-bed irradiation after local excision and axillary dissection for early breast cancer. Clin Oncol (R Coll Radiol). 2005; 17: 618-622.
  • 9
    Holmes DR, Baum M, Joseph D. The TARGIT trial: targeted intraoperative radiation therapy versus conventional postoperative whole-breast radiotherapy after breast-conserving surgery for the management of early-stage invasive breast cancer (a trial update). Am J Surg. 2007; 194: 507-510.
  • 10
    Ribeiro GG, Magee B, Swindell R, et al. The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol (R Coll Radiol). 1993; 5: 278-283.
  • 11
    Shaitelman SF, Vicini FA. Status of accelerated partial breast irradiation. Curr Breast Cancer Rep. 2010; 2: 59-66.
  • 12
    Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005; 366: 2087-2106.
  • 13
    Vinh-Hung V, Verschraegen C. Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst. 2004; 96: 115-121.
  • 14
    Smith BD, Arthur DW, Buchholz TA, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). J Am Coll Surg. 2009; 209: 269-277.
  • 15
    Smith BD, Arthur DW, Buchholz TA, et al. Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys. 2009; 74: 987-1001.
  • 16
    Nelson JC, Beitsch PD, Vicini FA, et al. Four-year clinical update from the American Society of Breast Surgeons MammoSite brachytherapy trial. Am J Surg. 2009; 198: 83-91.
  • 17
    Vicini F, Beitsch PD, Quiet CA, et al. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation. Cancer. 2008; 112: 758-766.
  • 18
    Vicini F, Beitsch P, Quiet C, et al. Five-year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI) [published online ahead of print May 14, 2010]. Int J Radiat Oncol Biol Phys. 2010.
  • 19
    Arthur DW, Vicini FA, Kuske RR, et al. Accelerated partial breast irradiation: an updated report from the American Brachytherapy Society. Brachytherapy. 2003; 2: 124-130.
  • 20
    Vicini F, Baglan K, Kestin L, et al. The emerging role of brachytherapy in the management of patients with breast cancer. Semin Radiat Oncol. 2002; 12: 31-39.
  • 21
    Cytyc Corporation. MammoSite: targeted radiation therapy. Available at: http://www.mammosite.com/physicians. Accessed January 19, 2010.
  • 22
    Vicini FA, Kestin LL, Goldstein NS. Defining the clinical target volume for patients with early-stage breast cancer treated with lumpectomy and accelerated partial breast irradiation: a pathologic analysis. Int J Radiat Oncol Biol Phys. 2004; 60: 722-730.
  • 23
    Khan AJ, Vicini F, Beitsch P, et al. Local control, toxicity, and cosmesis in women younger than 50 enrolled onto the American Society of Breast Surgeons MammoSite Radiation Therapy System Registry Trial. Ann Surg Oncol. 2009; 16: 1612-1618.
  • 24
    Patel RR, Christensen ME, Hodge CW, et al. Clinical outcome analysis in “high-risk” versus “low-risk” patients eligible for National Surgical Adjuvant Breast and Bowel B-39/Radiation Therapy Oncology Group 0413 trial: 5-year results. Int J Radiat Oncol Biol Phys. 2008; 70: 970-973.
  • 25
    Vicini F, Arthur D, Wazer D, et al. Limitation of the American Society of Therapeutic Radiology and Oncology (ASTRO) consensus panel guidelines on the use of accelerated partial breast irradiation [published online ahead of print, June 10, 2010]. Int J Radiat Oncol Biol Phys. 2010.